Illinois SR 803: HEPATITIS B VAC-SUPPORT

Bill Text

• 

 Illinois General Assembly - Full Text of SR0803 

• 

• 

• 

• 

• 

• 

• 

• 

• 

• 

• 

• 

 Select Language

 × 

 The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein.

 Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet.

 The English language version is always the official and authoritative version of this website.

 NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window.

 Choose Language 

 English 

 Afrikaans 

 Albanian 

 Arabic 

 Armenian 

 Azerbaijani 

 Basque 

 Bengali 

 Bosnian 

 Catalan 

 Croatian 

 Czech 

 Danish 

 Dutch 

 Esperanto 

 Estonian 

 Filipino 

 Finnish 

 French 

 Galician 

 Georgian 

 German 

 Greek 

 Gujarati 

 Haitian Creole 

 Hausa 

 Hawaiian 

 Hebrew 

 Hindi 

 Hungarian 

 Icelandic 

 Indonesian 

 Interlingua 

 Interlingue 

 Inuktitut 

 Irish 

 Italian 

 Japanese 

 Javanese 

 Kannada 

 Khmer 

 Korean 

 Latin 

 Latvian 

 Lithuanian 

 Luxembourgish 

 Macedonian 

 Malagasy 

 Malayalam 

 Maltese 

 Maori 

 Marathi 

 Myanmar 

 Nepali 

 Norwegian 

 Odia 

 Pashto 

 Punjabi 

 Romanian 

 Russian 

 Samoan 

 Sango 

 Sanskrit 

 Sardinian 

 Sindhi 

 Sinhala 

 Slovak 

 Slovenian 

 Somali 

 Southern Sotho 

 Spanish 

 Sundanese 

 Swahili 

 Swedish 

 Tamil 

 Telugu 

 Thai 

 Tigrinya 

 Tonga 

 Turkish 

 Ukrainian 

 Urdu 

 Vietnamese 

 Welsh 

 Xhosa 

 Yiddish 

 Yoruba 

 Zulu 

 Powered by Translate 

 Close 

 Illinois General Assembly

 Top Navigation Bar

 Translate 

 Learn 

 Select General Assembly 

 Search the 104th General Assembly 

 Enter search terms for legislation, members, committees, or schedules. 

 ILGA.GOV 

• 

• 

 LEGISLATION & LAWS 

• Bills & Resolutions 

• Public Acts 

• Illinois Compiled Statutes 

• Illinois Constitution 

• Search Legislation 

• Glossary 

• Guide 

• 

 Reports & Inquiry 

• Legislative Reports 

• Special Reports 

• FTP Site 

• Legislator Lookup 

• Capitol Complex Phone Numbers 

• 

 Rules & Regulations 

• Illinois Register 

• Administrative Rules 

• 

 Senate 

• 
 Members 

• Schedules 

• Committees 

• 

 Request for Remote Testimony 

• Journals 

• Transcripts 

• Rules 

• Audio/Video 

• FOIA Information 

• Senate Employment Opportunities 

• Media Guidelines 

• 

 House 

• 
 Members 

• Schedules 

• Committees 

• 

 Submit testimony for House Committees 

• Journals 

• Transcripts 

• Rules 

• Audio/Video 

• FOIA Information 

• House Employment Opportunities 

• Log In 

 Mobile Top Bar

 Search the 104th General Assembly 

 Enter keywords to search the Illinois General Assembly website. 

 Full Text of SR0803

• Home 

• Legislation 

• Full Text 

 SR0803 - 104th General Assembly 

• 
 Bill Status 

• 
 Full Text 

• 
 Votes 

• 
 Witness Slips 

 Select Menu 

 Bill Status 
 Full Text 
 Votes 
 Witness Slips 
 Printer Friendly Version 

 Introduced 

 Printer Friendly Version 

 Introduced 

 Open PDF 

SR0803LRB104 21923 MST 37825 r

1SENATE RESOLUTION

2 WHEREAS, Hepatitis B is a liver infection caused by the 

3hepatitis B virus, and current evidence indicates that 

4approximately 1.8 million Americans are infected with the 

5hepatitis B virus; it spreads from person to person via 

6contact with infected blood and/or body fluids, and hepatitis 

7B infections can range from an acute, mild, short-term illness 

8to a chronic, serious, long-term infection that can lead to 

9cirrhosis and liver cancer; infants exposed to hepatitis B 

10have a 90% risk of developing chronic hepatitis B compared to 

11adults at 5%, increasing their risk of developing liver cancer 

12or cirrhosis in their lifetimes; and

13 WHEREAS, A reported 85% of infants and 50% of older 

14children and adults with hepatitis B are asymptomatic, and 

15approximately 1 in 2 people who have hepatitis B are unaware of 

16their infection status and the need to safeguard infant 

17health; in 1991, the Advisory Committee on Immunization 

18Practices (ACIP) issued its first universal hepatitis B birth 

19dose recommendation, which led to the implementation of the 

20universal hepatitis B vaccination program in 1992 in the 

21United States; and

22 WHEREAS, Treatment reduces the risk of serious conditions 

23such as liver cancer or cirrhosis, but an estimate of up to 75% 

SR0803- 2 -LRB104 21923 MST 37825 r

1of people who have hepatitis B in the U.S. and are eligible for 

2treatment are not prescribed treatment, including 40% of those 

3with advanced liver disease; and

4 WHEREAS, A contemporary analysis of evidence on the 

5hepatitis B birth dose, conducted 35 years after the 

6implementation of the universal hepatitis B birth dose 

7recommendation,